Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Conferences
    • AACR20
    • AACR19
    • AACR18
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AACR IO
    • AAI ASGCT
    • ASCO GI
    • ASCO GU
    • ASCO-SITC
    • ASCO20
    • ASCO19
    • ASCO18
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASH19
    • ASH18
    • ASH17
    • ASH16
    • ASH15
    • AUA
    • BMT
    • CIML40
    • CIMT
    • EACR
    • EAU
    • ECCO
    • EHA iCML
    • ESMO20
    • ESMO19
    • ESMO18
    • ESMO17
    • ESMO16
    • ESMO14
    • JPM20
    • Mol Targets EORTC AACR NCI
    • SABCS
    • SITC 2020
    • SITC 2019
    • SITC 2018
    • SITC 2017
    • SITC 2016
    • SITC 2015
    • SITC 2014
  • Targets
    • Adenosine
    • Bispecifics
    • Cytokines
    • MYC
    • Neoantigens
    • RAS
    • STING
  • About
  • Contact
  • Pricing
  • Cell Therapy
  • Immuno-Oncology
  • ASH20
  • Premium Content
  • Interviews
  • Login

  • ASH20 Preview – Part 1 on small molecule developments

    Read more

  • ASH20 CAR-T cell therapy Preview

    Read more

  • When IO, targeted therapy and oncogene worlds collide

    Read more

  • Hot Topics: What we learned from SITC20 about an emerging class of oncology agents

    Read more

  • ASH20 Preview 2 on Antibodies and ADCs

    Read more

  • ASH20 Preview of progress with bispecific antibodies

    Read more
E

ASH20 Preview – Part 1 on small molecule developments

New developments in the BTK niche offer fresh insights on progress

View post
E

ASH20 CAR-T cell therapy Preview

Rock around the CAR-T cell clock to learn what to watch out for at ASH20!

View post
E

When IO, targeted therapy and oncogene worlds collide

Oncogenes and tumour suppressors can have surprising effects on targeted therapies and immunotherapies

View post

Terms of Use & Privacy Policy
Copyright © 2010-20 Biotech Strategy Blog

Free Email Updates
Subscribe to new post alerts, offers, and additional content!
We respect your privacy and do not sell emails. Unsubscribe at any time.
error: Content is protected !!